🇺🇸 FDA
Patent

US 11090310

Methods and compositions for treating hypertriglyceridemia

granted A61KA61K31/557A61P

Quick answer

US patent 11090310 (Methods and compositions for treating hypertriglyceridemia) held by The Regents of the University of California expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/557, A61P, A61P3/06